Methylenedioxynitazene

Methylenedioxynitazene
Identifiers
  • 2-(2-((1,3-benzodioxol-5-yl)methyl)-5-nitro-1H-benzo[d]imidazol-1-yl)-N,N-diethylethan-1-amine
CAS Number
Chemical and physical data
FormulaC21H24N4O4
Molar mass396.447 g·mol−1
3D model (JSmol)
  • CCN(CC)CCn4c(Cc2ccc1OCOc1c2)nc3cc([N+]([O-])=O)ccc34
  • InChI=InChI=1S/C21H24N4O4/c1-3-23(4-2)9-10-24-18-7-6-16(25(26)27)13-17(18)22-21(24)12-15-5-8-19-20(11-15)29-14-28-19/h5-8,11,13H,3-4,9-10,12,14H2,1-2H3
  • Key:RRRJUZFZCVIDSM-UHFFFAOYSA-N

Methylenedioxynitazene (3',4'-Methylenedioxynitazene) is a benzimidazole derivative which has been sold as a designer drug over the internet and presumably has opioid effects. It is an analogue of etonitazene where the benzyl ring is substituted with a 3,4-methylenedioxy ring system rather than an ethoxy group. It was first reported in the UK in early 2024.[1]

See also

References

  1. ^ "Fourth addendum to ACMD report on the use and harms of 2-benzyl benzimidazole ('nitazene') and piperidine benzimidazolone ('brorphine-like') opioids" (PDF). Advisory Council on the Misuse of Drugs. 5 April 2024.



This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.